ELDN
Eledon Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.62
−1.13%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.20
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.27
- EPS estimate
- -$0.16
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +2.7%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.16 | -$0.27 | Miss -70.89% | — |
| May 13, 2026 | -$0.22 | -$0.16 | Beat 27.27% | — |
| Mar 19, 2026 | -$0.20 | -$0.10 | Beat 50.00% | — |
| Nov 14, 2025 | -$0.22 | -$0.21 | Beat 4.55% | — |
| Aug 14, 2025 | -$0.23 | -$0.13 | Beat 43.48% | — |
| May 14, 2025 | -$0.28 | -$0.08 | Beat 71.43% | — |
| Mar 20, 2025 | -$0.32 | -$0.64 | Miss -100.00% | $192.0K |
| Aug 19, 2024 | -$0.31 | -$0.32 | Miss -3.23% | — |
| May 9, 2024 | -$0.37 | -$0.34 | Beat 8.11% | — |
| Nov 9, 2023 | -$0.41 | -$0.35 | Beat 14.63% | — |
| Aug 10, 2023 | -$0.47 | -$0.40 | Beat 14.89% | — |
| May 11, 2023 | -$0.71 | -$0.75 | Miss -5.63% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026